Clinical Trial Update: Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy for aggressive Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Lymphoma Trials Office | Conditions: Lymphoma | Phase 3 | Status: COMPLETED